Free Trial

Bio-Rad Laboratories (BIO) Earnings Date, Estimates & Call Transcripts

$296.82
-3.45 (-1.15%)
(As of 04:31 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1
After Market Closes
Confirmed
Actual EPS
(May. 7)
$2.29 Beat By $0.25
Consensus EPS
(May. 7)
$2.04
Skip Charts & View Estimated and Actual Earnings Data

BIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bio-Rad Laboratories Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$2.06$2.06$2.06 
Q2 20241$2.03$2.03$2.03 
Q3 20241$2.70$2.70$2.70 
Q4 20241$3.39$3.39$3.39 
FY 20244$10.18$10.18$10.18 
Q1 20251$2.40$2.40$2.40 
Q2 20251$2.63$2.63$2.63 
Q3 20251$3.44$3.44$3.44 
Q4 20251$2.99$2.99$2.99 
FY 20254$11.46$11.46$11.46 
Q1 20261$3.18$3.18$3.18 

BIO Earnings Date and Information

Bio-Rad Laboratories last released its quarterly earnings results on May 7th, 2024. The medical research company reported $2.29 earnings per share for the quarter, beating analysts' consensus estimates of $2.04 by $0.25. The firm had revenue of $610.82 million for the quarter, compared to analysts' expectations of $619.09 million. Its revenue for the quarter was down 9.8% compared to the same quarter last year. Bio-Rad Laboratories has generated ($10.36) earnings per share over the last year (($10.36) diluted earnings per share). Earnings for Bio-Rad Laboratories are expected to grow by 8.80% in the coming year, from $10.80 to $11.75 per share. Bio-Rad Laboratories has confirmed that its next quarterly earnings report will be published on Thursday, August 1st, 2024. Bio-Rad Laboratories will be holding an earnings conference call on Thursday, August 1st at 5:00 PM Eastern. Interested parties can register for or listen to the call..

Bio-Rad Laboratories Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Confirmed)
-------  
5/7/2024Q1 2024$2.04$2.29+$0.25($8.87)$619.09 million$610.82 million    
2/15/2024Q4 2023$2.93$3.10+$0.17($5.94)$685.00 million$681.18 million      
10/26/2023Q3 2023$2.87$2.33($0.54)$1.02$689.50 million$632.10 million      
8/3/2023Q2 2023$2.55$3.00+$0.45$45.59$697.96 million$681.10 million      
5/4/2023Q1 2023$3.24$3.34+$0.10$4.36$689.28 million$676.80 million      
2/16/2023Q4 2022$3.45$3.31($0.14)($21.16)$741.01 million$730.29 million      
10/27/2022Q3 2022$2.59$2.60+$0.01$10.72$685.50 million$680.10 million    
7/28/2022Q2 2022$2.46$3.38+$0.92$37.88$664.60 million$691.10 million    
4/28/2022Q1 2022$2.80$4.94+$2.14$122.45$678.00 million$700.10 million      
2/10/2022Q4 2021$2.87$3.21+$0.34$59.01$731.94 million$732.80 million    
10/28/2021Q3 2021$2.30$3.71+$1.41($122.54)$670.36 million$747.00 million    
7/28/2021Q2 2021$2.66$3.54+$0.88($23.24)$610.40 million$715.93 million    
4/29/2021Q1 2021$2.50$5.21+$2.71($21.96)$661.00 million$726.80 million  
2/10/2021Q4 2020$3.30$4.01+$0.71($19.79)$681.80 million$789.84 million  
10/29/2020Q3 2020$1.85$3.00+$1.15($37.64)$567.35 million$647.26 million    
7/30/2020Q2 2020$1.22$1.61+$0.39($28.93)$526.80 million$536.88 million  
5/6/2020Q1 2020$1.57$1.91+$0.34($18.90)$545.70 million$571.60 million    
2/13/2020Q4 2019$2.44$2.32($0.12)($13.67)$636.50 million$624.43 million  
10/31/2019Q3$1.36$1.61+$0.25$11.90$561.40 million$560.60 million  
8/1/2019Q2 2019$1.39$1.57+$0.18($16.72)$564.88 million$572.60 million    

Bio-Rad Laboratories Earnings - Frequently Asked Questions

When is Bio-Rad Laboratories's earnings date?

Bio-Rad Laboratories has confirmed that its next quarterly earnings data will be published on Thursday, August 1st, 2024. Learn more on BIO's earnings history.

What guidance has Bio-Rad Laboratories issued on next quarter's earnings?

Bio-Rad Laboratories updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company issued revenue guidance of $2.7 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion.

Did Bio-Rad Laboratories beat their earnings estimates last quarter?

In the previous quarter, Bio-Rad Laboratories (NYSE:BIO) reported $2.29 earnings per share (EPS) to beat the analysts' consensus estimate of $2.04 by $0.25. Learn more on analysts' earnings estimate vs. BIO's actual earnings.

How can I listen to Bio-Rad Laboratories's earnings conference call?

The conference call for Bio-Rad Laboratories's latest earnings report can be listened to online. Listen to Conference Call

How can I read Bio-Rad Laboratories's conference call transcript?

The conference call transcript for Bio-Rad Laboratories's latest earnings report can be read online. Read Transcript

How much revenue does Bio-Rad Laboratories generate each year?

Bio-Rad Laboratories (NYSE:BIO) has a recorded annual revenue of $2.67 billion.

How much profit does Bio-Rad Laboratories generate each year?

Bio-Rad Laboratories (NYSE:BIO) has a recorded net income of -$637.32 million. BIO has generated -$10.36 earnings per share over the last four quarters.

What is Bio-Rad Laboratories's EPS forecast for next year?

Bio-Rad Laboratories's earnings are expected to grow from $10.80 per share to $11.75 per share in the next year, which is a 8.80% increase.


More Earnings Resources from MarketBeat

This page (NYSE:BIO) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners